Dyne Stock Rises on FDA Fast Track Label (DYN:NASDAQ)
Dyne Stock Rises on FDA Fast Track Label (DYN:NASDAQ)


hapabapa

  • Therapeutic Dina (NASDAQ:DIN) announced Tuesday that the U.S. Food and Drug Administration (FDA) issued a fast-track designation for DYNE-101, an experimental therapy for a rare muscle disorder called myotonic dystrophy type 1 (DM1).
  • DYNE-101, a drug with orphan drug designation in the

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *